Insider Transactions in Q4 2023 at Sonnet Bio Therapeutics Holdings, Inc. (SONN)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2023
|
John Harry Cross Iii Chief Financial Officer |
SELL
Grant, award, or other acquisition
|
Direct |
1,452
-47.76%
|
-
|
|
Dec 11
2023
|
Richard T Kenney Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,271
+48.05%
|
-
|
|
Dec 11
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,554
+33.51%
|
-
|
|
Dec 11
2023
|
Donald J. Griffith Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
317
+45.81%
|
-
|
|
Dec 11
2023
|
John K. Cini Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,888
+47.15%
|
-
|
|
Dec 11
2023
|
Raghu Rao Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
373
+13.67%
|
-
|
|
Dec 11
2023
|
Albert D. Dyrness Director |
BUY
Grant, award, or other acquisition
|
Direct |
373
+40.99%
|
-
|
|
Dec 11
2023
|
Lori Mc Neill Director |
BUY
Grant, award, or other acquisition
|
Direct |
373
+48.63%
|
-
|
|
Dec 11
2023
|
Susan Dexter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+46.91%
|
-
|
|
Dec 11
2023
|
Nailesh Bhatt Director |
BUY
Grant, award, or other acquisition
|
Direct |
373
+40.54%
|
-
|
|
Oct 27
2023
|
Pankaj Mohan Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
34,375
+36.61%
|
-
|
|
Oct 27
2023
|
Raghu Rao Interim CEO |
BUY
Open market or private purchase
|
Direct |
15,625
+48.17%
|
-
|